Lino

Linum usitatissimum L.

Bibliografia

  • [BHC]
  • [BHP]
  • [Wren]
  • Allman MA, Pena MM, Pang D. (1995) Supplementation with flaxseed oil versus sunflowerseed oil in healthy young men consuming a low fat diet: effects on platelet composition and function. Eur J Clin Nutr.;49:169-178.
  • Bierenbuam ML, Reichstein R, Watkins TR. (1993) Reducing atherogenic risk in hyperlipemic humans with flax seed supplementation: a preliminary report. J Am Coll Nutr.;12:501-504.
  • Clark WF, et al. (1995) Flaxseed: a potential treatment of lupusb nephritis. Kidney International.;48:475-480.
  • Cunnane SC, et al (1993) High alpha-linolenic acid flaxseed (Linum usitatissimum): some nutritional properties in humans. Br J Nutr.; 69:443-453.
  • Cunnane SC. (1995) Nutritional attributes of traditional flaxseed in healthy-young adults. Am J Clin Nutr. ;61:62-68.
  • Fluckiger, F. & Hanbury, D. (1885) Pharmacographia - The History of the Principle Drugs of Vegetable Origin. Reprinted Delhi (1986)
  • Gruenwald J. Brendler T, Christof J. (1998) PDR for Herbal Medicines. Montvale, NJ: Medical Economics Company; :940-941.
  • Prasad K, Mantha S, Muir A, Westcott N. (1998) Reduction of hypercholesterolemic arteriosclerosis by CDC-flaxseed with very low alpha-linolenic acid. Arteriosclerosis.; 434:367-375.
  • Serraino M, Thompson L. (1992) The effect of flaxseed supplementation on the initiation and promotional stages of mammary tumorigenesis. Nutr Cancer.; 25:153-159.
  • Sung M, Lautens M, Thompson L. (1998) Mammalian lignans inhibit the growth of estrogen-independent human colon tumor cells. Anticancer Research.;1346:1405-1408.
  • Thompson L, Richard S, Orcheson L, Seidl M. (1996) Flaxseed and its lignan and oil components reduce mammary tumor growth at a late stage of carcinogenesis. Carcinogenesis.;434:1373-1376.
  • Yan L, Yee J, Li D, McGuire M, Thompson L. (1998) Dietary flaxseed supplementation and experimental metastasis of melanoma cells in mice. Cancer Lett.; 61:181-186.